Results 201 to 210 of about 28,350 (246)
Some of the next articles are maybe not open access.
Dynamic restoration of dystrophin to dystrophin-deficient myotubes
Muscle & Nerve, 2001Dystrophin domains are observed in myoblast transplantation experiments and in muscle fibers after somatic reversion in human Duchenne and mdx mouse muscular dystrophy. However, the formation and evolution of dystrophin-positive domains are not well established.
J, Kong, J E, Anderson
openaire +2 more sources
Molecular Extensibility of Mini-dystrophins and a Dystrophin Rod Construct
Journal of Molecular Biology, 2005Muscular dystrophies arise with various mutations in dystrophin, implicating this protein in force transmission in normal muscle. With 24 three-helix, spectrin repeats interspersed with proline-rich hinges, dystrophin's large size is an impediment to gene therapy, prompting the construction of mini-dystrophins.
Nishant, Bhasin +7 more
openaire +2 more sources
Annals of Neurology, 1998
AbstractA muscle biopsy from an X‐linked muscular dystrophy pedigree showed normal dystrophin and dystrophinassociated proteins. Linkage to multiple markers within the dystrophin gene (LOD = 2.7, ⊖ = O) indicated a primary dystrophinopathy. Sequencing of the entire dystrophin RNA revealed a single missense mutation (D3335H) in the unique carboxyl ...
L R, Goldberg +5 more
openaire +2 more sources
AbstractA muscle biopsy from an X‐linked muscular dystrophy pedigree showed normal dystrophin and dystrophinassociated proteins. Linkage to multiple markers within the dystrophin gene (LOD = 2.7, ⊖ = O) indicated a primary dystrophinopathy. Sequencing of the entire dystrophin RNA revealed a single missense mutation (D3335H) in the unique carboxyl ...
L R, Goldberg +5 more
openaire +2 more sources
Treatment of dystrophin cardiomyopathies
Nature Reviews Cardiology, 2014Treatment of cardiac disease in patients with dystrophinopathies substantially improves outcomes. In this Review, we summarize and discuss findings from the past 20 years and future perspectives for therapeutic options to treat cardiovascular disease in these patients. Their cardiac disease can be subclinical or symptomatic.
Josef, Finsterer, Linda, Cripe
openaire +2 more sources
Dystrophin and the membrane skeleton
Current Opinion in Cell Biology, 1993Recent studies have confirmed several predictions concerning the structure and possible function of dystrophin, including a direct interaction with F-actin and an indirect interaction with laminin via linkage through a transmembrane protein complex. The results of the past year support a role for dystrophin in linking the actin cytoskeleton with the ...
J M, Ervasti, K P, Campbell
openaire +2 more sources
The dystrophin connection — ATP?
Medical Hypotheses, 1992Clinical evidence is presented supporting the hypothesis that the metabolic abnormality in the dystrophin-defective muscular dystrophies (DMD and BMD) involves the ATP pathway. Objective laboratory data show corrective trends in the abnormal values of parameters relating to creatine and calcium metabolism (ATP) by use of glucagon-stimulated c-AMP and ...
C A, Bonsett, A, Rudman
openaire +2 more sources
Biochemistry, 1993
Dystrophin, an elongated cytoskeletal molecule which is deficient in Duchenne muscular disease, contains an actin-binding domain in its N-terminal portion. We show that this part interacted with actin in the native molecule. By molecular biology techniques, four recombinant proteins were expressed in Escherichia coli using the pMAL vector which allowed
E, Fabbrizio +3 more
openaire +2 more sources
Dystrophin, an elongated cytoskeletal molecule which is deficient in Duchenne muscular disease, contains an actin-binding domain in its N-terminal portion. We show that this part interacted with actin in the native molecule. By molecular biology techniques, four recombinant proteins were expressed in Escherichia coli using the pMAL vector which allowed
E, Fabbrizio +3 more
openaire +2 more sources
A quantitative ELISA for dystrophin
Journal of Immunological Methods, 1993A novel approach to the quantitation of the muscular dystrophy protein, dystrophin, in muscle extracts is described. The two-site ELISA uses two monoclonal antibodies against dystrophin epitopes which lie close together in the rod domain of the dystrophin molecule in order to minimize the effects of dystrophin degradation.
G E, Morris, J M, Ellis, T M, Nguyen
openaire +2 more sources
The muscular dystrophies and dystrophin
Current Opinion in Neurology, 1993Recent progress in molecular genetics has resulted in more insight in the molecular biology of muscles and the muscular dystrophies, and has provided more reliable tools for prenatal and presymptomatic diagnosis in several disorders. The state of research is reviewed with emphasis on genetic aspects.
openaire +2 more sources
Expression of Dystrophins and the Dystrophin-Associated-Protein Complex by Pituicytes in Culture
Neurochemical Research, 2011The dystrophin-associated-protein complex (DAPC) has been extensively characterized in the central nervous system where it is localized both in neuronal and glial cells. Few studies have characterized this complex in the neurohypophysis. To further study this complex in pituicytes, the resident astroglia of the neurophypophysis, we used adult pituicyte
Bougrid, Abdelkader +7 more
openaire +2 more sources